secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0001213900-22-032102
Event type: leadership
Sentiment:  negative
Materiality: 0.75
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea Therapeutics CFO Stanley Gloss passes away; search for replacement underway
--------------------------------------------------------------------------------

- Stanley Gloss, CFO of Pasithea Therapeutics, passed away on June 7, 2022.
- Company has commenced a search for a new Chief Financial Officer.
- No other officer or board changes were announced in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390022032102/0001213900-22-032102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390022032102/ea161275-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-032102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer